SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
Don’t Chase American Virtual Cloud Technologies Higher
3 Stocks With Market-Beating Price Performance
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
NASDAQ:IRTC

iRhythm Technologies - IRTC Stock Forecast, Price & News

$132.37
-4.40 (-3.22%)
(As of 10/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$131.36
$138.38
50-Day Range
$118.83
$160.42
52-Week Range
$61.24
$169.54
Volume
203,590 shs
Average Volume
485,699 shs
Market Capitalization
$3.98 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$161.36

iRhythm Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.70 Rating Score
Upside/​Downside
21.9% Upside
$161.36 Price Target
Short Interest
Healthy
5.19% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.25mentions of iRhythm Technologies in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$1.79 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.07) to ($2.66) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

315th out of 1,075 stocks

Surgical & Medical Instruments Industry

34th out of 104 stocks

IRTC stock logo

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Stock News Headlines

IRTC iRhythm Technologies, Inc.
iRhythm Technologies, Inc. (IRTC)
6 Analysts Have This to Say About iRhythm Technologies
Expert Ratings for iRhythm Technologies
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Company Calendar

Last Earnings
8/04/2022
Today
10/07/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$161.36
High Stock Price Forecast
$198.00
Low Stock Price Forecast
$105.00
Forecasted Upside/Downside
+21.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Net Income
$-101,360,000.00
Pretax Margin
-36.08%

Debt

Sales & Book Value

Annual Sales
$322.83 million
Book Value
$9.50 per share

Miscellaneous

Free Float
29,535,000
Market Cap
$3.98 billion
Optionable
Optionable
Beta
1.53

Key Executives

  • Mr. Quentin S. Blackford (Age 43)
    Pres, CEO & Director
    Comp: $671.81k
  • Mr. Douglas J. DevineMr. Douglas J. Devine (Age 52)
    COO, CFO & Sec.
    Comp: $1.14M
  • Mr. Mark J. Day Ph.D. (Age 51)
    Chief Technology Officer
    Comp: $718.76k
  • Mr. Daniel G. WilsonMr. Daniel G. Wilson (Age 40)
    Exec. VP of Strategy, Corp. Devel. & Investor Relations
    Comp: $670.09k
  • Mr. David A. VortMr. David A. Vort (Age 56)
    Strategic Advisor
    Comp: $896.16k
  • Mr. Brice Bobzien CPA
    Chief Financial Officer
  • Dr. Mintu P. Turakhia M.D.
    Chief Medical Officer & Chief Scientific Officer
  • Mr. Patrick Michael Murphy J.D. (Age 43)
    Chief Legal Officer
  • Ms. Reyna M. Fernandez (Age 55)
    Exec. VP & Chief HR Officer
  • Ms. Dietra N. Jones
    Exec. VP of Clinical Operations













IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last year. There are currently 1 sell rating, 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price forecast for 2022?

10 brokerages have issued 1 year price objectives for iRhythm Technologies' shares. Their IRTC share price forecasts range from $105.00 to $198.00. On average, they anticipate the company's stock price to reach $161.36 in the next year. This suggests a possible upside of 21.9% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2022?

iRhythm Technologies' stock was trading at $117.69 on January 1st, 2022. Since then, IRTC shares have increased by 12.5% and is now trading at $132.37.
View the best growth stocks for 2022 here
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) issued its earnings results on Thursday, August, 4th. The company reported ($0.79) earnings per share for the quarter, beating the consensus estimate of ($0.94) by $0.15. The company earned $102.10 million during the quarter, compared to analyst estimates of $100.51 million. iRhythm Technologies had a negative trailing twelve-month return on equity of 38.95% and a negative net margin of 36.15%. iRhythm Technologies's revenue for the quarter was up 25.6% on a year-over-year basis. During the same quarter last year, the business posted ($0.59) EPS.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2027 earnings guidance on Wednesday, October, 5th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.00B-.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Fulton Bank N.A. (0.01%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Matthew C Garrett, Merz Cathleen Noel Bairey, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $132.37.

How much money does iRhythm Technologies make?

iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $3.97 billion and generates $322.83 million in revenue each year. The company earns $-101,360,000.00 in net income (profit) each year or ($4.42) on an earnings per share basis.

How many employees does iRhythm Technologies have?

The company employs 1,700 workers across the globe.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.